A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression
- PMID: 17202547
- DOI: 10.1176/ajp.2007.164.1.73
A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression
Abstract
Objective: Repetitive transcranial magnetic stimulation (rTMS) has been reported to be as effective as electroconvulsive therapy (ECT) for major depression. The authors conducted a multicenter randomized, controlled trial to test the equivalence of rTMS with ECT.
Method: Forty-six patients with major depression referred for ECT were randomly assigned to either a 15-day course of rTMS of the left dorsolateral prefrontal cortex (N=24) or a standard course of ECT (N=22). The primary outcome measures were the score on the 17-item Hamilton Depression Rating Scale (HAM-D) and the proportion of patients with remissions (Hamilton score, <or=8) at the end of treatment. Secondary outcomes included mood self-ratings on the Beck Depression Inventory-II and visual analogue mood scales, Brief Psychiatric Rating Scale (BPRS) score, and both self-reported and observer-rated cognitive changes. The patients were followed up after 6 months.
Results: HAM-D scores at the end of treatment were significantly lower for ECT, with 13 patients (59.1%) achieving remission in the ECT group and four (16.7%) in the rTMS group. However, at 6 months the HAM-D scores did not differ between groups. Beck scale, visual analogue mood scale, and BPRS scores were lower for ECT at the end of treatment and remained lower after 6 months. Self- and observer-rated cognitive measures were similar in the two groups.
Conclusions: rTMS was not as effective as ECT, and ECT was substantially more effective for the short-term treatment of depression.
Comment in
-
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression.Am J Psychiatry. 2007 Jul;164(7):1118; author reply 1118-9. doi: 10.1176/ajp.2007.164.7.1118a. Am J Psychiatry. 2007. PMID: 17606665 No abstract available.
-
Repetitive transcranial magnetic stimulation is not as effective as electroconvulsive therapy for major depression.Evid Based Ment Health. 2007 Aug;10(3):78. doi: 10.1136/ebmh.10.3.78. Evid Based Ment Health. 2007. PMID: 17652560 No abstract available.
Similar articles
-
A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.Psychol Med. 2008 Mar;38(3):323-33. doi: 10.1017/S0033291707001663. Epub 2007 Oct 15. Psychol Med. 2008. PMID: 17935639 Clinical Trial.
-
The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.Health Technol Assess. 2007 Jul;11(24):1-54. doi: 10.3310/hta11240. Health Technol Assess. 2007. PMID: 17580003 Clinical Trial.
-
Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial.J Affect Disord. 2008 Aug;109(3):273-85. doi: 10.1016/j.jad.2008.01.001. Epub 2008 Feb 11. J Affect Disord. 2008. PMID: 18262655 Clinical Trial.
-
Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis.Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:181-9. doi: 10.1016/j.pnpbp.2014.02.004. Epub 2014 Feb 18. Prog Neuropsychopharmacol Biol Psychiatry. 2014. PMID: 24556538 Review.
-
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Ont Health Technol Assess Ser. 2016 Mar 1;16(5):1-66. eCollection 2016. Ont Health Technol Assess Ser. 2016. PMID: 27099642 Free PMC article. Review.
Cited by
-
The neurobiological mechanisms and therapeutic prospect of extracellular ATP in depression.CNS Neurosci Ther. 2024 Feb;30(2):e14536. doi: 10.1111/cns.14536. CNS Neurosci Ther. 2024. PMID: 38375982 Free PMC article. Review.
-
Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS.Biol Mood Anxiety Disord. 2012 Aug 17;2:14. doi: 10.1186/2045-5380-2-14. Biol Mood Anxiety Disord. 2012. PMID: 22901565 Free PMC article.
-
Repetitive transcranial magnetic stimulation to maintain treatment response to electroconvulsive therapy in depression: a case series.Front Psychiatry. 2013 Jul 23;4:73. doi: 10.3389/fpsyt.2013.00073. eCollection 2013. Front Psychiatry. 2013. PMID: 23888145 Free PMC article.
-
Repetitive transcranial magnetic stimulation: a psychiatric treatment of the future?Ir J Med Sci. 2006 Oct-Dec;175(4):82. doi: 10.1007/BF03167978. Ir J Med Sci. 2006. PMID: 17315290 No abstract available.
-
APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline.Transl Psychiatry. 2021 Oct 5;11(1):507. doi: 10.1038/s41398-021-01631-0. Transl Psychiatry. 2021. PMID: 34611141 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources